Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **ventrolateral geniculate nucleus (vLGN)** is a subdivision of the thalamus found in rodents and other mammals that receives input from retinal ganglion cells and projects primarily to subcortical sensorimotor structures rather than directly relaying information to the cortex[2][5][6]. Within the vLGN, several types of neurochemically distinct neurons exist—including those expressing **enkephalins**, which are endogenous opioid peptides involved in neuromodulation[1][3][6]. Enkephalinergic neurons in the vLGN participate in circuits regulating non-image-forming visual functions such as circadian rhythm entrainment and visuomotor integration[1][5]. These cells share many properties with similar populations found in adjacent regions like the intergeniculate leaflet (IGL), including expression of GABA and other neuropeptides such as neuropeptide Y[1][3]. While these neurons play important roles at the circuit level—modulating sensory input integration relevant for behavioral state regulation—they do not constitute discrete molecular targets suitable for direct pharmacological intervention under current scientific paradigms. Their function relates more broadly to thalamocortical circuitry underlying vision-linked behaviors and biological timing systems rather than being individually druggable entities.
Not applicable for this neuronal subtype itself; however, endogenous opioids like enkephalins modulate synaptic transmission via activation of opioid receptors on these and other neurons.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ventrolateral geniculate nucleus enkephalinergic neuron.